{"id":"https://openalex.org/W7147573743","doi":"https://doi.org/10.1158/0008-5472.31923385","title":"Supplemental Figure 19 from Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer","display_name":"Supplemental Figure 19 from Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer","publication_year":2026,"publication_date":"2026-04-02","ids":{"openalex":"https://openalex.org/W7147573743","doi":"https://doi.org/10.1158/0008-5472.31923385"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.31923385","doi":"https://doi.org/10.1158/0008-5472.31923385","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31923385","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.31923385","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088533475","display_name":"Sarah K. Herzog","orcid":"https://orcid.org/0000-0003-3782-7389","observed_orcids":["https://orcid.org/0000-0003-3782-7389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah K. Herzog","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3782-7389","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053532805","display_name":"Jessica H. Stevens","orcid":"https://orcid.org/0009-0005-9741-9928","observed_orcids":["https://orcid.org/0009-0005-9741-9928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica H. Stevens","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-9741-9928","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022101967","display_name":"Guowei gu","orcid":"https://orcid.org/0000-0001-8845-4055","observed_orcids":["https://orcid.org/0000-0001-8845-4055"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guowei Gu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8845-4055","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055660362","display_name":"Sandra L. Grimm","orcid":"https://orcid.org/0000-0002-0682-3134","observed_orcids":["https://orcid.org/0000-0002-0682-3134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra L. Grimm","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0682-3134","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120061357","display_name":"Kloma T Cardoza","orcid":"https://orcid.org/0009-0006-0488-7894","observed_orcids":["https://orcid.org/0009-0006-0488-7894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kloma Cardoza","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-0488-7894","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122007666","display_name":"Autumn G.M. Hawkins","orcid":"https://orcid.org/0009-0001-8189-3159","observed_orcids":["https://orcid.org/0009-0001-8189-3159"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Autumn G.M. Hawkins","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-8189-3159","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022989159","display_name":"Hangqing Lin","orcid":"https://orcid.org/0009-0009-7691-8364","observed_orcids":["https://orcid.org/0009-0009-7691-8364"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hangqing Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-7691-8364","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008477330","display_name":"Daniela Ramos","orcid":"https://orcid.org/0000-0002-8940-0232","observed_orcids":["https://orcid.org/0000-0002-8940-0232","https://orcid.org/0000-0002-3848-6478"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Ramos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3848-6478","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027523922","display_name":"Amanda R. Beyer","orcid":"https://orcid.org/0009-0009-9244-1439","observed_orcids":["https://orcid.org/0009-0009-9244-1439"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda R. Beyer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-9244-1439","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132660789","display_name":"David G. Edwards","orcid":"https://orcid.org/0000-0001-8002-0607","observed_orcids":["https://orcid.org/0000-0001-8002-0607"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David G. Edwards","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8002-0607","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074873339","display_name":"Derek J. Dustin","orcid":"https://orcid.org/0000-0002-3566-0282","observed_orcids":["https://orcid.org/0000-0002-3566-0282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Derek Dustin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3566-0282","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121999354","display_name":"Harry J. Yang","orcid":"https://orcid.org/0009-0008-8758-5705","observed_orcids":["https://orcid.org/0009-0008-8758-5705"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harry J. Yang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-8758-5705","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132625812","display_name":"Nicole Liang","orcid":"https://orcid.org/0009-0009-7459-8360","observed_orcids":["https://orcid.org/0009-0009-7459-8360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole Liang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-7459-8360","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001922429","display_name":"Ashfia Fatima Khan","orcid":"https://orcid.org/0000-0002-1730-5383","observed_orcids":["https://orcid.org/0000-0002-1730-5383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashfia F. Khan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1730-5383","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132732093","display_name":"Tasneem Bawa-Khalfe","orcid":"https://orcid.org/0000-0002-5376-4392","observed_orcids":["https://orcid.org/0000-0002-5376-4392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tasneem Bawa-Khalfe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5376-4392","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060285832","display_name":"Daniel James McGrail","orcid":"https://orcid.org/0000-0002-6669-6069","observed_orcids":["https://orcid.org/0000-0002-6669-6069","https://orcid.org/0000-0002-3729-2487"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. McGrail","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6669-6069","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044419431","display_name":"Shiaw\u2010Yih Lin","orcid":"https://orcid.org/0000-0002-3838-0358","observed_orcids":["https://orcid.org/0000-0002-3838-0358"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiaw-Yih Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3838-0358","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052755605","display_name":"Cristian Coarfa","orcid":"https://orcid.org/0000-0002-4183-4939","observed_orcids":["https://orcid.org/0000-0002-4183-4939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristian Coarfa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4183-4939","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054255756","display_name":"Suzanne A.W. Fuqua","orcid":"https://orcid.org/0000-0001-8886-5161","observed_orcids":["https://orcid.org/0000-0001-8886-5161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suzanne A.W. Fuqua","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8886-5161","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.8659999966621399},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8399999737739563},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9369999766349792},{"id":"https://openalex.org/keywords/poly-adp-ribose-polymerase","display_name":"poly(ADP-ribose) polymerase","score":0.5720000267028809},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.9070000052452087},{"id":"https://openalex.org/keywords/estrogen-deprivation","display_name":"estrogen deprivation","score":0.5429999828338623},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.8579999804496765},{"id":"https://openalex.org/keywords/veliparib","display_name":"veliparib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9139999747276306},{"id":"https://openalex.org/keywords/therapeutic-vulnerabilities","display_name":"therapeutic vulnerabilities","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.6808000206947327},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.6017000079154968},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.5174999833106995},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5139999985694885},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.5134999752044678},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4975999891757965},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.487199991941452},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.47519999742507935},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4603999853134155},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4065999984741211},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.3747999966144562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37139999866485596},{"id":"https://openalex.org/C95713431","wikidata":"https://www.wikidata.org/wiki/Q631425","display_name":"Vulnerability (computing)","level":2,"score":0.3637000024318695},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.3582000136375427},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33570000529289246},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33489999175071716},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3257000148296356},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3188000023365021},{"id":"https://openalex.org/C85265743","wikidata":"https://www.wikidata.org/wiki/Q885458","display_name":"Blot","level":3,"score":0.301800012588501},{"id":"https://openalex.org/C130840561","wikidata":"https://www.wikidata.org/wiki/Q2344000","display_name":"Dot blot","level":3,"score":0.29829999804496765},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.26930001378059387}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.31923385","doi":"https://doi.org/10.1158/0008-5472.31923385","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31923385","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.31923385","doi":"https://doi.org/10.1158/0008-5472.31923385","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31923385","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7118669765","https://openalex.org/W7147056485","https://openalex.org/W4390636623","https://openalex.org/W4384126490","https://openalex.org/W4389948617","https://openalex.org/W4385285406","https://openalex.org/W7062043182","https://openalex.org/W4361281158","https://openalex.org/W4396587106"],"abstract_inverted_index":{"Olap":[0],"increases":[1],"chromatin":[2,12,59],"retention":[3],"of":[4,15,26,38,62,73,85],"PARP":[5],"a.":[6],"Western":[7,54],"blot":[8,55],"analysis":[9,56],"showing":[10,57],"the":[11,58,97],"bound":[13,60],"fraction":[14,61],"MCF-7":[16,63],"WT,":[17,64],"Y537S,":[18,65],"Y537C":[19,66],"and":[20,45,67],"F+A":[21,68],"cells":[22,69],"after":[23,70],"48":[24,36,71],"hours":[25,37,72,84],"estrogen":[27,74],"deprivation":[28,75],"in":[29,76],"charcoal":[30,77],"stripped":[31,78],"serum":[32,79],"media":[33,80],"followed":[34,81],"by":[35,82],"combination":[39],"treatment":[40,86],"with":[41,87,96],"10":[42],"nM":[43],"Fulvestrant":[44],"5":[46,88,92],"uM":[47,89,93],"Olaparib":[48,90],"compared":[49],"to":[50],"untreated":[51],"controls.":[52],"b.":[53],"72":[83],"or":[91],"Veliparib,":[94],"isolated":[95],"ThermoFisher":[98],"subcellular":[99],"protein":[100],"fractionation":[101],"kit.":[102]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2026-04-02T00:00:00"}